Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$1.8M
Filings
76
Firms Hired
1
Active Period
1999–2022
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Indian Health Service Health Professions Tax Fairness Act of 2021
2021 · fourth_quarter · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
S. 2874 The Indian Health Service Health Professions Tax Fairness Act Signed onto letter in support of S 2874 the Indian Health Service Health Professions Tax Fairness Act of 2021 sent to congressional leadership led by AI/AN Health Partners. Thank you letter to Senators Cortez Masto and Murkowski for introducing S. 2874, the Indian Health Service Health Professions Tax Fairness Act of 2021. This important bill would amend the tax code to provide health care professionals who receive student loan repayments and scholarships from the Indian Health Service (IHS) the same tax-free status enjoyed by those who receive National Health Service Corps (NHSC) loan repayments.
Client expense: $30,000 · Firm income: —
Matched citations: S 2874, S. 2874
RISE Act of 2021
2021 · first_quarter · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
AACP signed onto the Ad Hoc Group FY 2022 funding request for a program level of at least $46.1 billion for the NIH, a $3.2 billion increase, or an increase of BRDPI + 5% (7.4%), over the FY 2021 program level. (This funding level includes the full $496 million NIH is scheduled to receive in FY 2022 from the Innovation Account established in the 21st Century Cures Act for specific programs.) As part of its recommendation for the NIH funding level, the coalition is also recommending a robust commitment to discretionary spending programs, including the Labor-HHS-Education allocation, as well as emergency supplemental funding to support Covid-19 related expenses on both pandemic- and non-pandemic research. AACP joined the Friends of AHRQ in sending a letter to leadership of the House and Senate Appropriations Committees to request no less than $500 million for AHRQ in FY22. AACP signed onto a Friends of NICHD letter to House and Senate Appropriations Committees leaders endorsing the Ad Hoc Group for Medical Research FY 2022 funding recommendation, which would give the NIH $46.1 billion, a $3.2 billion increase over the agencyas FY 2021 level, and calling for NICHD to receive a proportionate funding increase, bringing its funding to $1.7 billion in Fiscal Year (FY) 2022, an increase of $117 million over FY 2021. The letter also calls for direct emergency supplemental appropriation for NICHD to support pandemic-related research. AACP joined a Friends of NIDDK letter to House and Senate Leadership and House and Senate Chairs and Ranking Members of Appropriations Committees and Labor-HHS Subcommittees to support the research communityas FY 2022 NIH funding recommendation of at least $46.111 billion, a $3.177 billion increase over the comparable FY 2021 funding level for the NIH, which would allow for the NIHas base budget to keep pace with the biomedical research and development price index (BRDPI) of 2.3 % and allow meaningful growth of 5%. We request a proportionate increase for the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) of at least $157 million for a total of $2.289 billion in FY 2022. The letter also also strongly encourages Congress to provide supplemental emergency funding of $10 billion for NIH, ensure dedicated support for the NIDDK to enable critical COVID-related research, and support research recovery from the impact of the pandemic. AACP signed letter urging Acting HHS Secretary Cochran to withdraw the proposed rule (RIN 0991-AC-15) on extramural research involving human fetal tissue (HFT). The proposed rule would impede promising biomedical research that could lead to new treatments for serious diseases, including COVID-19. AACP signed onto letter requesting that Congress appropriate $50 million in Fiscal Year (FY) 2022 for the CDC and NIH to conduct research on firearm injury and mortality prevention. AACP signed onto a letter led by Research!America asking for support for the Investment to Spark the Economy (RISE) Act (H.R.869/S.289) and request and support full funding for the initiatives it would create in any relevant proposal that advances. AACP signed onto a letter led by FOVA expressing FY22 funding recommendations.
Client expense: $30,000 · Firm income: —
Matched citations: H.R.869
RISE Act of 2021
2021 · first_quarter · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
AACP signed onto the Ad Hoc Group FY 2022 funding request for a program level of at least $46.1 billion for the NIH, a $3.2 billion increase, or an increase of BRDPI + 5% (7.4%), over the FY 2021 program level. (This funding level includes the full $496 million NIH is scheduled to receive in FY 2022 from the Innovation Account established in the 21st Century Cures Act for specific programs.) As part of its recommendation for the NIH funding level, the coalition is also recommending a robust commitment to discretionary spending programs, including the Labor-HHS-Education allocation, as well as emergency supplemental funding to support Covid-19 related expenses on both pandemic- and non-pandemic research. AACP joined the Friends of AHRQ in sending a letter to leadership of the House and Senate Appropriations Committees to request no less than $500 million for AHRQ in FY22. AACP signed onto a Friends of NICHD letter to House and Senate Appropriations Committees leaders endorsing the Ad Hoc Group for Medical Research FY 2022 funding recommendation, which would give the NIH $46.1 billion, a $3.2 billion increase over the agencyas FY 2021 level, and calling for NICHD to receive a proportionate funding increase, bringing its funding to $1.7 billion in Fiscal Year (FY) 2022, an increase of $117 million over FY 2021. The letter also calls for direct emergency supplemental appropriation for NICHD to support pandemic-related research. AACP joined a Friends of NIDDK letter to House and Senate Leadership and House and Senate Chairs and Ranking Members of Appropriations Committees and Labor-HHS Subcommittees to support the research communityas FY 2022 NIH funding recommendation of at least $46.111 billion, a $3.177 billion increase over the comparable FY 2021 funding level for the NIH, which would allow for the NIHas base budget to keep pace with the biomedical research and development price index (BRDPI) of 2.3 % and allow meaningful growth of 5%. We request a proportionate increase for the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) of at least $157 million for a total of $2.289 billion in FY 2022. The letter also also strongly encourages Congress to provide supplemental emergency funding of $10 billion for NIH, ensure dedicated support for the NIDDK to enable critical COVID-related research, and support research recovery from the impact of the pandemic. AACP signed letter urging Acting HHS Secretary Cochran to withdraw the proposed rule (RIN 0991-AC-15) on extramural research involving human fetal tissue (HFT). The proposed rule would impede promising biomedical research that could lead to new treatments for serious diseases, including COVID-19. AACP signed onto letter requesting that Congress appropriate $50 million in Fiscal Year (FY) 2022 for the CDC and NIH to conduct research on firearm injury and mortality prevention. AACP signed onto a letter led by Research!America asking for support for the Investment to Spark the Economy (RISE) Act (H.R.869/S.289) and request and support full funding for the initiatives it would create in any relevant proposal that advances. AACP signed onto a letter led by FOVA expressing FY22 funding recommendations.
Client expense: $30,000 · Firm income: —
Matched citations: S.289
Addressing COVID-19 Health Disparities Act
2020 · fourth_quarter · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
AACP signed Ad Hoc group letter urging Congressional leaders to include at least $15.5 billion in emergency funding for NIH, to support research and costs of lost productivity associated with COVID-19, in supplemental legislation, as included in the Senate HEALS Act. AACP signed a letter led by Friends of AHRQ endorsing Congressman Don Beyer's bill H.R. 8067. The bill would direct AHRQ to conduct or support research on the most critical health system issues for COVID-19,
Client expense: $30,000 · Firm income: —
Matched citations: H.R. 8067
Addressing COVID-19 Health Disparities Act
2020 · third_quarter · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
AACP signed a letter led by Friends of AHRQ endorsing Congressman Don Beyer's bill H.R. 8067. The bill would direct AHRQ to conduct or support research on the most critical health system issues for COVID-19, including on the expansion and efficacy of telehealth, evaluating and identifying potential weaknesses in the health system that increase racial and ethnic disparities in COVID-19 infection rates and develop strategies for mitigating them, and creating protocols that ensure that vulnerable groups have timely access to safe and effective COVID-19 vaccines. AACP signed Ad Hoc group letter urging Congressional leaders to include at least $15.5 billion in emergency funding for NIH, to support research and costs of lost productivity associated with COVID-19, in supplemental legislation, as included in the Senate HEALS Act.
Client expense: $30,000 · Firm income: —
Matched citations: H.R. 8067
The Heroes Act
2020 · second_quarter · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
Joined TFAH, APHA, ASTHO, BPC Action, NACCHO, and PHAB in an organizational sign-on letter to congressional leadership in support of increased, sustained annual funding for state/local/tribal/territorial public health infrastructure. Signed onto letter to the Senate (McConnell, Schumer, Murkowski, Udall) led by AI/AN Partners to ask for funding for tribes and IHS to effectively respond to COVID-19, including at least a match of funding level in H.R. 6800, the HEROES Act, for the Bureau of Indian Affairs and Indian Health Service. The letter also urged inclusion of S. 2871, the Indian Health Service Health Professions Tax Fairness Act, in the next coronavirus response bill.
Client expense: $30,000 · Firm income: —
Matched citations: H.R. 6800
Indian Health Service Health Professions Tax Fairness Act of 2019
2020 · second_quarter · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
Joined TFAH, APHA, ASTHO, BPC Action, NACCHO, and PHAB in an organizational sign-on letter to congressional leadership in support of increased, sustained annual funding for state/local/tribal/territorial public health infrastructure. Signed onto letter to the Senate (McConnell, Schumer, Murkowski, Udall) led by AI/AN Partners to ask for funding for tribes and IHS to effectively respond to COVID-19, including at least a match of funding level in H.R. 6800, the HEROES Act, for the Bureau of Indian Affairs and Indian Health Service. The letter also urged inclusion of S. 2871, the Indian Health Service Health Professions Tax Fairness Act, in the next coronavirus response bill.
Client expense: $30,000 · Firm income: —
Matched citations: S. 2871
United States Public Health Service Modernization Act of 2019
2019 · fourth_quarter · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE - UNITED STATES PUBLIC HEALTH SERVICE MODERNIZATON ACT (S. 2629) Signed onto letter led by the American Indian/Alaska Natives (AI/AN) Partners coalition urging the Senate Health, Education, Labor and Pensions (HELP) Committee to approve S. 2629, the United States Public Health Service Modernization Act of 2019. The bill would create a Ready Reserve Corps for the Public Health Services Commissioned Corps. HOUSE - 21ST CENTURY CURES 2.0 ACT The Pharmacy Health Information Technology Collaborative submitted comments to cures2@mail.house.gov in support of pharmacists being recognized as health care practitioners in all telehealth and digital health technology proposals put forward, payment codes for their services provided. SENATE - Letter to Senate Indian Affairs Committee Signed AI/AN Partners letter to the Senate Indian Affairs Committee in support of Rear Admiral Michael Weahkees nomination as Director of IHS. HHS - OIG Signed onto AKS Proposed Rule on Medicare and State Healthcare Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute, and Civil Monetary Penalty Rules Regarding Beneficiary Inducements Proposed Rule (OIG-0936-AA10-P) letter lead by pharmacy organizations.
Client expense: $30,000 · Firm income: —
Matched citations: S. 2629
Indian Health Service Health Professions Tax Fairness Act of 2019
2019 · fourth_quarter · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
Senate - Cosponsor S.2871 Indian Health Service Health Professions Tax Fairness Act of 2019 Signed onto letter urging Senators to cosponsor S. 2871 the Indian Health Service Health Professions Tax Fairness Act of 2019. The bill seeks to amend the tax code to provide health care professionals who receive student loan repayments and scholarships from the Indian Health Service (IHS) the same tax-free status enjoyed by those who receive National Health Service Corps (NHSC) loan repayments. Under the IHS and NHSC programs, health care professionals provide needed care and services to underserved populations.
Client expense: $30,000 · Firm income: —
Matched citations: S. 2871, S.2871
Extreme Risk Protection Order Act of 2019
2019 · third_quarter · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
HOUSE - H.R. 1236 the Extreme Risk Protection Order Act Contacted by Representative Carbajal to sign on in support of their introduction of H.R. 1236 the Extreme Risk Protection Order Act.
Client expense: $30,000 · Firm income: —
Matched citations: H.R. 1236
REACH Act
2019 · third_quarter · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
HOUSE/SENATE - LABOR-HHS-EDUCATION SUBCOMMITTEE LETTER Signed onto letter led by friends of AHRQ as House and Senate begin Fiscal 2020 conference negotiations amongst appropriators urging them to support a final funding level equal to, or above the House-passed level of $358.2 million for AHRQ. HOUSE/SENATE - H.R. 2328 Reauthorizing and Extending Americas Community Health Act Signed coalition letter led by NIDDK to House and Senate leaders (Reps. Nancy Pelosi and Kevin McCarthy and Sens. Mitch McConnell and Charles Schumer) urging reauthorization of the Special Diabetes Program through H.R. 2328 Reauthorizing and Extending America's Community Health Act or the "REACH Act." HOUSE/SENATE - LABOR-HHS-EDUCATION SUBCOMMITTEE LETTER Signed onto letter led by the Ad Hoc Group Steering Committee for Medical Research urging House and Senate appropriators to ensure quick enactment of Labor-HHS-Education appropriations bill that provides robust, sustained funding for medical research. This letter has an emphasis on NIH funding. SENATE - Funding Bill FY20 Signed onto Giffords Coalition letter urging Senate leadership to include the House passed Fiscal Year 2020 Labor, Health and Human Services, Education, and Related Agencies funding bill, which includes $50 million for the Centers for Disease Control and Prevention (CDC) and National Institutes of Health (NIH) to conduct research into gun violence.
Client expense: $30,000 · Firm income: —
Matched citations: H.R. 2328
American Dream and Promise Act of 2019
2019 · third_quarter · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE - DREAM ACT (S. 874/H.R. 6) Signed onto Health Professionals Coalition letter in support of the DREAM Act (S. 874/H.R. 6). This letter urges the Senate to adopt H.R. 6 the Dream and Promise Act recently passed by the House or to pass S. 874 the Dream Act a similar measure introduced by Senators Graham and Durbin. SENATE - Letter to Secretary Azar of Department of HHS Singed onto letter led by the Coalition on Fetal Tissue Research expressing concerns regarding two NIH guide notices Changes to NIH Requirements Regarding Proposed Human Fetal Tissue Research and Clarifying Competing Application Instructions and Notice of Publication of Frequently Asked Questions (FAQs) Regarding Proposed Human Fetal Tissue Research. The letter sent to Secretary Azar expresses concerns that both the policy underlying these notices (i.e., the requirement that human fetal tissue research proposals be subject to an additional layer of review) and the specific requirements of these notices will create substantial barriers to important biomedical research, jeopardize the integrity of the peer-review process, and create an unnecessarily cumbersome and bureaucratic process for reviewing crucial research.
Client expense: $30,000 · Firm income: —
Matched citations: H.R. 6
Strengthening Health Care and Lowering Prescription Drug Costs Act
2019 · third_quarter · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
HOUSE - H.R. 987/Discussion of Pharmacy Education Visiting Office of office Rep. Lucy McBath in response to an amendment offered by the representative to H.R. 987. The amendment calls for DHHS and DoEd to do all needed outreach to make sure faculty and students at colleges of pharmacy have all necessary materials about generic drugs and biosimilar biological products. AACP welcomes the representatives support for pharmacists and pharmacy students.
Client expense: $30,000 · Firm income: —
Matched citations: H.R. 987
Dream Act of 2019
2019 · third_quarter · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE - DREAM ACT (S. 874/H.R. 6) Signed onto Health Professionals Coalition letter in support of the DREAM Act (S. 874/H.R. 6). This letter urges the Senate to adopt H.R. 6 the Dream and Promise Act recently passed by the House or to pass S. 874 the Dream Act a similar measure introduced by Senators Graham and Durbin. SENATE - Letter to Secretary Azar of Department of HHS Singed onto letter led by the Coalition on Fetal Tissue Research expressing concerns regarding two NIH guide notices Changes to NIH Requirements Regarding Proposed Human Fetal Tissue Research and Clarifying Competing Application Instructions and Notice of Publication of Frequently Asked Questions (FAQs) Regarding Proposed Human Fetal Tissue Research. The letter sent to Secretary Azar expresses concerns that both the policy underlying these notices (i.e., the requirement that human fetal tissue research proposals be subject to an additional layer of review) and the specific requirements of these notices will create substantial barriers to important biomedical research, jeopardize the integrity of the peer-review process, and create an unnecessarily cumbersome and bureaucratic process for reviewing crucial research.
Client expense: $30,000 · Firm income: —
Matched citations: S. 874
Investing for the People Act of 2019
2019 · second_quarter · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE/HOUSE - FY 2020 Raise the Caps Signed onto letter addressed to Congress urging to raise the cap on domestic and international discretionary spending for fiscal years 2020 and 2021. Failure to raise the caps will result in sharply reduced funding for domestic and international discretionary programs (together known as non-defense or NDD) from $597 billion in FY 2019 to $543 billion in FY 2020, a $54 billion drop, or 9 percent, not counting inflation. SENATE - FY20 Labor, Health and Human Services, and Education and Related Agencies Appropriations Request Singed onto bill led by the CDC Coalition addressed to Sen. Blunt and Sen. Murray urging the Senate to match the $8.22 billion provided to CDC programs in the HOUSE FY 2020 Labor, Health and Human Services, and Education, and Related Agencies bill totaling $225 million from the HHS Nonrecurring Expenses Fund. HOUSE - IHS Health Workforce Signed onto letter led by the AI/AN Health Partners group to House Interior Appropriations committee requesting improved funding for the IHS Health Workforce. BUD - HHS - Letter to Secretary Azar on Fetal Tissue Signed onto letter led by International Society for Stem Cell Research to Secretary Azar voicing opposition to new policies on research using human fetal tissue announced by HHS. HOUSE - H.R. 2021 Investing for People Act of 2019 Officially endorsed H.R. 2021 Investing for People Act of 2019 introduced by Representative John Yarmuth to increase discretionary spending limits and increases both defense and nondefence discretionary spending limits for FY20 and FY21. HOUSE - H.R. 2741 LIFT America Act Signed onto letter in support of H.R. 2741 the Leading Infrastructure for Tomorrows (LIFT) America Act introduced by House Democrats of the Energy and Commerce committee.
Client expense: $30,000 · Firm income: —
Matched citations: H.R. 2021
Leading Infrastructure for Tomorrow’s America Act
2019 · second_quarter · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE/HOUSE - FY 2020 Raise the Caps Signed onto letter addressed to Congress urging to raise the cap on domestic and international discretionary spending for fiscal years 2020 and 2021. Failure to raise the caps will result in sharply reduced funding for domestic and international discretionary programs (together known as non-defense or NDD) from $597 billion in FY 2019 to $543 billion in FY 2020, a $54 billion drop, or 9 percent, not counting inflation. SENATE - FY20 Labor, Health and Human Services, and Education and Related Agencies Appropriations Request Singed onto bill led by the CDC Coalition addressed to Sen. Blunt and Sen. Murray urging the Senate to match the $8.22 billion provided to CDC programs in the HOUSE FY 2020 Labor, Health and Human Services, and Education, and Related Agencies bill totaling $225 million from the HHS Nonrecurring Expenses Fund. HOUSE - IHS Health Workforce Signed onto letter led by the AI/AN Health Partners group to House Interior Appropriations committee requesting improved funding for the IHS Health Workforce. BUD - HHS - Letter to Secretary Azar on Fetal Tissue Signed onto letter led by International Society for Stem Cell Research to Secretary Azar voicing opposition to new policies on research using human fetal tissue announced by HHS. HOUSE - H.R. 2021 Investing for People Act of 2019 Officially endorsed H.R. 2021 Investing for People Act of 2019 introduced by Representative John Yarmuth to increase discretionary spending limits and increases both defense and nondefence discretionary spending limits for FY20 and FY21. HOUSE - H.R. 2741 LIFT America Act Signed onto letter in support of H.R. 2741 the Leading Infrastructure for Tomorrows (LIFT) America Act introduced by House Democrats of the Energy and Commerce committee.
Client expense: $30,000 · Firm income: —
Matched citations: H.R. 2741
American Dream and Promise Act of 2019
2019 · second_quarter · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE - DREAM Act S. 874 Signed onto letter lead by the Health Professionals Coalition addressed to Sens. McConnell, Schumer, Graham, Feinstein urging the Senate to adopt H.R. 6 the Dream and Promise Act passed by the House of Representatives or to pass S. 874 the Dream Act a similar measure introduced by Senators Graham and Durbin.
Client expense: $30,000 · Firm income: —
Matched citations: H.R. 6
Strengthening Health Care and Lowering Prescription Drug Costs Act
2019 · second_quarter · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE - Public Health Funding Restoration Act Worked with Senator Richard Blumenthal (D-CT) on supporting the introduction of the Public Health Restoration Act and signed on as a supporting organization. ADMINISTRATION - Letter to White House, OMB, POTUS and HHS Opposing FDA Guidance Signed onto letter led by Friends of Cancer research to the Administration, Mick Mulvaney, Russel Vought, Trump and Alexander Azar voicing opposition to FDA guidance documents. SENATE - Cannabidiol and Marijuana Research Expansion Act Signed letter led by American Psychological Association addressed to Senate leaders asking for the reintroduction of the Cannabidiol and Marijuana Research Expansion Act. HOUSE - Rep. Buddy Carter Amendment Rec. to H.R. 987 Strengthening Healthcare and Lowering Prescription Drug Cost Act Contacted by Rep. Buddy Carters office regarding amendment to H.R. 987 Strengthening Healthcare and Lower Prescription Drug Cost Act which included provision regarding outreach to colleges of pharmacy by the Secretary of HHS and Education with respect to materials related to generic drugs and biosimilar.
Client expense: $30,000 · Firm income: —
Matched citations: H.R. 987
Dream Act of 2019
2019 · second_quarter · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE - DREAM Act S. 874 Signed onto letter lead by the Health Professionals Coalition addressed to Sens. McConnell, Schumer, Graham, Feinstein urging the Senate to adopt H.R. 6 the Dream and Promise Act passed by the House of Representatives or to pass S. 874 the Dream Act a similar measure introduced by Senators Graham and Durbin.
Client expense: $30,000 · Firm income: —
Matched citations: S. 874
Investing for the People Act of 2019
2019 · second_quarter · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE/HOUSE - FY 2020 Raise the Caps Signed onto letter addressed to Congress urging to raise the cap on domestic and international discretionary spending for fiscal years 2020 and 2021. Failure to raise the caps will result in sharply reduced funding for domestic and international discretionary programs (together known as non-defense or NDD) from $597 billion in FY 2019 to $543 billion in FY 2020, a $54 billion drop, or 9 percent, not counting inflation. SENATE - FY20 Labor, Health and Human Services, and Education and Related Agencies Appropriations Request Singed onto bill led by the CDC Coalition addressed to Sen. Blunt and Sen. Murray urging the Senate to match the $8.22 billion provided to CDC programs in the HOUSE FY 2020 Labor, Health and Human Services, and Education, and Related Agencies bill totaling $225 million from the HHS Nonrecurring Expenses Fund. HOUSE - IHS Health Workforce Signed onto letter led by the AI/AN Health Partners group to House Interior Appropriations committee requesting improved funding for the IHS Health Workforce. HHS - Letter to Secretary Azar on Fetal Tissue Signed onto letter led by International Society for Stem Cell Research to Secretary Azar voicing opposition to new policies on research using human fetal tissue announced by HHS. HOUSE - H.R. 2021 Investing for People Act of 2019 Officially endorsed H.R. 2021 Investing for People Act of 2019 introduced by Representative John Yarmuth to increase discretionary spending limits and increases both defense and nondefence discretionary spending limits for FY20 and FY21. HOUSE - H.R. 2741 LIFT America Act Signed onto letter in support of H.R. 2741 the Leading Infrastructure for Tomorrows (LIFT) America Act introduced by House Democrats of the Energy and Commerce committee.
Client expense: $30,000 · Firm income: —
Matched citations: H.R. 2021
Leading Infrastructure for Tomorrow’s America Act
2019 · second_quarter · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE/HOUSE - FY 2020 Raise the Caps Signed onto letter addressed to Congress urging to raise the cap on domestic and international discretionary spending for fiscal years 2020 and 2021. Failure to raise the caps will result in sharply reduced funding for domestic and international discretionary programs (together known as non-defense or NDD) from $597 billion in FY 2019 to $543 billion in FY 2020, a $54 billion drop, or 9 percent, not counting inflation. SENATE - FY20 Labor, Health and Human Services, and Education and Related Agencies Appropriations Request Singed onto bill led by the CDC Coalition addressed to Sen. Blunt and Sen. Murray urging the Senate to match the $8.22 billion provided to CDC programs in the HOUSE FY 2020 Labor, Health and Human Services, and Education, and Related Agencies bill totaling $225 million from the HHS Nonrecurring Expenses Fund. HOUSE - IHS Health Workforce Signed onto letter led by the AI/AN Health Partners group to House Interior Appropriations committee requesting improved funding for the IHS Health Workforce. HHS - Letter to Secretary Azar on Fetal Tissue Signed onto letter led by International Society for Stem Cell Research to Secretary Azar voicing opposition to new policies on research using human fetal tissue announced by HHS. HOUSE - H.R. 2021 Investing for People Act of 2019 Officially endorsed H.R. 2021 Investing for People Act of 2019 introduced by Representative John Yarmuth to increase discretionary spending limits and increases both defense and nondefence discretionary spending limits for FY20 and FY21. HOUSE - H.R. 2741 LIFT America Act Signed onto letter in support of H.R. 2741 the Leading Infrastructure for Tomorrows (LIFT) America Act introduced by House Democrats of the Energy and Commerce committee.
Client expense: $30,000 · Firm income: —
Matched citations: H.R. 2741
American Dream and Promise Act of 2019
2019 · second_quarter · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE - DREAM Act S. 874 Signed onto letter lead by the Health Professionals Coalition addressed to Sens. McConnell, Schumer, Graham, Feinstein urging the Senate to adopt H.R. 6 the Dream and Promise Act passed by the House of Representatives or to pass S. 874 the Dream Act a similar measure introduced by Senators Graham and Durbin.
Client expense: $30,000 · Firm income: —
Matched citations: H.R. 6
Strengthening Health Care and Lowering Prescription Drug Costs Act
2019 · second_quarter · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE - Public Health Funding Restoration Act Worked with Senator Richard Blumenthal (D-CT) on supporting the introduction of the Public Health Restoration Act and signed on as a supporting organization. ADMINISTRATION - Letter to White House, OMB, POTUS and HHS Opposing FDA Guidance Signed onto letter led by Friends of Cancer research to the Administration, Mick Mulvaney, Russel Vought, Trump and Alexander Azar voicing opposition to FDA guidance documents. SENATE - Cannabidiol and Marijuana Research Expansion Act Signed letter led by American Psychological Association addressed to Senate leaders asking for the reintroduction of the Cannabidiol and Marijuana Research Expansion Act. HOUSE - Rep. Buddy Carter Amendment Rec. to H.R. 987 Strengthening Healthcare and Lowering Prescription Drug Cost Act Contacted by Rep. Buddy Carters office regarding amendment to H.R. 987 Strengthening Healthcare and Lower Prescription Drug Cost Act which included provision regarding outreach to colleges of pharmacy by the Secretary of HHS and Education with respect to materials related to generic drugs and biosimilar.
Client expense: $30,000 · Firm income: —
Matched citations: H.R. 987
Dream Act of 2019
2019 · second_quarter · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
SENATE - DREAM Act S. 874 Signed onto letter lead by the Health Professionals Coalition addressed to Sens. McConnell, Schumer, Graham, Feinstein urging the Senate to adopt H.R. 6 the Dream and Promise Act passed by the House of Representatives or to pass S. 874 the Dream Act a similar measure introduced by Senators Graham and Durbin.
Client expense: $30,000 · Firm income: —
Matched citations: S. 874
Aim Higher Act
2019 · first_quarter · Firm: AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
Reauthorization of the Higher Education Act; H.R. 4508 - Promoting Real Opportunity, Success and Prosperity through Education Reform Act; H. R. 6543 - The Aim Higher Act; Graduate and professional education; GRAD Plus; Public Service Loan Forgiveness; Student loan issues affecting pharmacy education; Interprofessional education issues; Title IX reform
Client expense: $27,000 · Firm income: —
Matched citations: H. R. 6543
Source: Senate LDA